Created at Source Raw Value Validated value
June 27, 2024, 4 p.m. usa

inclusion criteria: * aged 18 years or older at enrolment. * have received two doses of bnt162b2 or two doses of coronavac, with the most recent dose at least six months prior to enrolment. * currently resident and planning to remain resident in hong kong during the duration of the study, i.e. for 12 months after enrolment. * agreement to refrain from blood donation during the course of the study. * willing to provide blood samples for all the required time points. * the individual or their caregiver have a home phone or cellular or mobile phone for communications purpose. * capable of providing informed consent.

inclusion criteria: * aged 18 years or older at enrolment. * have received two doses of bnt162b2 or two doses of coronavac, with the most recent dose at least six months prior to enrolment. * currently resident and planning to remain resident in hong kong during the duration of the study, i.e. for 12 months after enrolment. * agreement to refrain from blood donation during the course of the study. * willing to provide blood samples for all the required time points. * the individual or their caregiver have a home phone or cellular or mobile phone for communications purpose. * capable of providing informed consent.

Sept. 28, 2021, 8 a.m. usa

inclusion criteria: - aged 18 years or older at enrolment. - have received two doses of bnt162b2 or two doses of coronavac, with the most recent dose at least six months prior to enrolment. - currently resident and planning to remain resident in hong kong during the duration of the study, i.e. for 12 months after enrolment. - agreement to refrain from blood donation during the course of the study. - willing to provide blood samples for all the required time points. - the individual or their caregiver have a home phone or cellular or mobile phone for communications purpose. - capable of providing informed consent.

inclusion criteria: - aged 18 years or older at enrolment. - have received two doses of bnt162b2 or two doses of coronavac, with the most recent dose at least six months prior to enrolment. - currently resident and planning to remain resident in hong kong during the duration of the study, i.e. for 12 months after enrolment. - agreement to refrain from blood donation during the course of the study. - willing to provide blood samples for all the required time points. - the individual or their caregiver have a home phone or cellular or mobile phone for communications purpose. - capable of providing informed consent.